|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,642 GBX | +0.40% |
|
+3.60% | +13.12% |
| Apr. 24 | CureVac Begins Early Stage Portion of Investigational Vaccine Trial | MT |
| Apr. 24 | Global markets live: Heineken, AT&T Hasbro, Visa, Boeing... |  |
Jan 11 (Reuters) - GlaxoSmithKline PLC:
* ELIGO BIOSCIENCE SA - ANNOUNCED THAT IT HAS ENTERED INTO A RESEARCH AND OPTION AGREEMENT WITH GLAXOSMITHKLINE Source text for Eikon: Further company coverage:
| 1st Jan change | Capi. | |
|---|---|---|
| +13.12% | 83.1B | |
| +25.61% | 660B | |
| +24.05% | 562B | |
| -5.24% | 358B | |
| +16.49% | 322B | |
| +8.28% | 297B | |
| +12.49% | 219B | |
| -9.73% | 196B | |
| +6.85% | 199B | |
| -8.75% | 149B |
GSK PLC 
